# Methylation Patterns of the NUPR1, MGMT, NDRG2, and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients

> **NCT06538428** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 78 (actual)

## Conditions studied

- GBM

## Interventions

- **GENETIC:** DNA methylation profiling

## Key facts

- **NCT ID:** NCT06538428
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06538428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06538428, "Methylation Patterns of the NUPR1, MGMT, NDRG2, and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06538428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*